Login to Your Account



30th AnnualJ.P. Morgan Healthcare Conference

What Venture Contraction? Flagship Closes $270M Fund

By Jennifer Boggs
Managing Editor

Thursday, January 12, 2012
SAN FRANCISCO – A day after Canaan Partners disclosed a $600 million fund – a third of that dedicated to the life sciences – Flagship Ventures closed a $270 million round, well above its $250 million fundraising goal.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription